- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 271/06 - Esters of carbamic acids
Patent holdings for IPC class C07C 271/06
Total number of patents in this class: 48
10-year publication summary
3
|
2
|
1
|
3
|
3
|
1
|
4
|
5
|
1
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Soprema | 83 |
4 |
BASF SE | 20933 |
2 |
Colgate-Palmolive Company | 5808 |
2 |
FUJIFILM Corporation | 29367 |
2 |
Mitsui Chemicals, Inc. | 3215 |
2 |
Asahi Kasei Chemicals Corporation | 681 |
2 |
Lantern Pharma Inc. | 76 |
2 |
Inkbit, LLC | 75 |
2 |
Glioblastoma Foundation, Inc. | 6 |
2 |
Chorda Pharma, Inc. | 5 |
2 |
Boehringer Ingelheim International GmbH | 4650 |
1 |
Bayer MaterialScience AG | 801 |
1 |
Dow Global Technologies LLC | 10363 |
1 |
The General Hospital Corporation | 4733 |
1 |
Alkermes Pharma Ireland Limited | 11 |
1 |
Axalta Coating Systems IP Co., LLC | 476 |
1 |
Barclays Bank plc, AS Successor Agent | 146 |
1 |
The Brigham and Women's Hospital, Inc. | 2188 |
1 |
BYK-Chemie GmbH | 443 |
1 |
Concert Pharmaceuticals, Inc. | 247 |
1 |
Other owners | 16 |